TSS:Hg 196379.1

Basic information about the TSS

---

TSS ID: hg_196379.1 Species: human Chr: chrX		Start: 51895338 End: 51895350 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF381477 MA617054 Distance: -65 GeneID: 9500 HGNC/MGI_ID: HGNC:6813 UniProt_ID:

Gene_name: MAGED1 Gene_symbol: MAGED1 Gene_synonyms: DLXIN-1 NRAGE Gene_source: HGNC:6813

TATA-Box annotation

---

Distance to TSS:	1721
Nearest PromoterID:	NM_001005333
Entrez ID:	9500
Nearest Unigene:	Hs.5258
Nearest Refseq:	NM_006986
Nearest Ensembl:	ENSG00000179222
Gene Name:	MAGED1
Gene Alias:	DLXIN-1|NRAGE
Gene Description:	MAGE family member D1
Gene Type:	protein-coding
CpG%:	0.005
GC%:	0.497512
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MAGED1 p2@MAGED1
Sample		p1@MAGED1	p2@MAGED1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.08	37.01
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.34	37.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.64	35.49
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.07	35.76
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.37	33.07
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	27.13	37.41
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.44	59.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	18.17	49.90
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.81	39.32
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	45.21
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	40.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	35.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	144.43	49.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	132.16	49.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	133.05	48.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	128.76	42.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	123.62	50.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	154.81	40.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	141.82	46.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	147.88	52.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	145.15	40.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	152.77	45.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	116.98	37.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	107.26	36.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	126.93	43.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	152.88	44.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	137.91	47.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	147.82	59.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	133.10	40.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	112.38	43.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	119.54	47.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	130.12	41.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	140.76	39.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	134.59	53.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	112.01	46.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	105.97	45.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	107.71	44.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	94.90	39.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	123.71	41.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	113.07	42.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	94.57	33.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	115.21	40.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	95.11	42.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	114.69	47.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	119.06	44.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	141.91	42.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	109.88	45.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	129.65	49.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	124.71	44.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	139.11	50.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	137.93	53.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	199.25	56.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	142.65	49.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	163.04	43.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	130.87	25.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	190.13	37.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	163.03	53.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	141.31	44.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	229.15	42.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	162.16	57.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	172.72	42.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	255.56	35.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	242.59	46.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	192.03	60.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	161.16	43.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	126.36	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	190.62	36.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	217.69	39.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	218.14	41.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	244.75	49.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	196.74	54.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	208.21	44.03
Adipocyte - breast, donor1	11376-118A8	258.32	27.88
Adipocyte - breast, donor2	11327-117E4	230.53	31.44
Adipocyte - omental, donor1	11473-119C6	369.72	36.51
Adipocyte - omental, donor2	11474-119C7	293.76	24.67
Adipocyte - omental, donor3	11475-119C8	257.89	29.81
Adipocyte - perirenal, donor1	11476-119C9	440.85	35.73
Adipocyte - subcutaneous, donor1	11259-116F8	133.04	17.59
Adipocyte - subcutaneous, donor2	11336-117F4	169.36	41.10
Adipocyte - subcutaneous, donor3	11408-118E4	57.35	31.28
Adipocyte differentiation, day04, donor1	13019-139D4	247.79	41.46
Adipocyte differentiation, day04, donor2	13022-139D7	249.14	27.54
Adipocyte differentiation, day04, donor3	13025-139E1	149.14	38.75
Adipocyte differentiation, day04, donor4	13028-139E4	147.54	29.98
Adipocyte differentiation, day08, donor1	13020-139D5	148.16	85.26
Adipocyte differentiation, day08, donor2	13023-139D8	117.16	41.64
Adipocyte differentiation, day08, donor3	13026-139E2	117.83	34.66
Adipocyte differentiation, day08, donor4	13029-139E5	94.59	48.97
Adipocyte differentiation, day12, donor1	13021-139D6	121.02	44.50
Adipocyte differentiation, day12, donor2	13024-139D9	78.11	38.18
Adipocyte differentiation, day12, donor3	13027-139E3	80.18	46.80
Adipocyte differentiation, day12, donor4	13030-139E6	78.25	61.50
Alveolar Epithelial Cells, donor1	11510-119G7	309.18	42.65
Alveolar Epithelial Cells, donor2	11590-120G6	175.71	40.88
Alveolar Epithelial Cells, donor3	11671-122G6	228.82	44.33
Amniotic Epithelial Cells, donor1	11533-120A3	370.97	67.46
Amniotic Epithelial Cells, donor2	11613-122A2	568.99	90.37
Amniotic Epithelial Cells, donor3	11694-123A2	463.28	68.00
Anulus Pulposus Cell, donor1	11248-116E6	495.81	64.65
Anulus Pulposus Cell, donor2	11463-119B5	398.22	55.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	250.71	36.39
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	303.46	39.51
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	222.59	21.40
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	265.74	33.78
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	261.78	29.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	205.94	29.04
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	257.63	29.24
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	280.58	35.44
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	219.14	30.29
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	253.85	30.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	292.45	31.20
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	195.59	30.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	249.25	29.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	279.78	38.21
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	240.66	30.31
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	287.72	42.86
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	277.55	27.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	274.50	31.01
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	261.42	33.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	271.51	29.19
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	180.11	27.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	247.81	60.18
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	283.71	31.22
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	222.33	37.75
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	269.90	40.29
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	294.45	23.15
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	244.70	26.65
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	265.07	35.91
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	315.10	26.29
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	246.73	29.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	293.25	41.76
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	282.64	27.01
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	189.06	22.83
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	241.00	25.15
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	271.87	29.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	192.45	41.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	251.74	25.43
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	237.11	28.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	205.86	26.05
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	282.22	38.84
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	252.75	23.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	214.01	26.97
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	270.19	44.40
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	252.42	24.07
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	245.53	41.69
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	302.10	50.70
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	278.31	28.52
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	246.08	26.47
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	252.23	38.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	271.26	29.88
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	232.08	43.36
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	248.64	27.71
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	323.70	33.44
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	233.78	24.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	285.37	32.03
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	285.60	26.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	199.88	24.41
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	244.82	33.23
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	294.98	25.16
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	222.07	29.80
Astrocyte - cerebellum, donor1	11500-119F6	755.81	95.43
Astrocyte - cerebellum, donor2	11580-120F5	636.37	70.18
Astrocyte - cerebellum, donor3	11661-122F5	558.98	80.12
Astrocyte - cerebral cortex, donor1	11235-116D2	346.49	62.05
Astrocyte - cerebral cortex, donor2	11316-117D2	253.18	51.61
Astrocyte - cerebral cortex, donor3	11392-118C6	327.56	66.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	128.33	108.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	114.13	116.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	143.61	114.25
Basophils, donor1	12241-129G9	4.45	12.55
Basophils, donor2	12242-129H1	4.33	27.06
Basophils, donor3	12243-129H2	43.36	12.79
Bronchial Epithelial Cell, donor1	11511-119G8	82.79	37.73
Bronchial Epithelial Cell, donor2	11591-120G7	151.33	34.75
Bronchial Epithelial Cell, donor3	11672-122G7	179.34	43.04
Bronchial Epithelial Cell, donor4	11453-119A4	37.03	15.69
Bronchial Epithelial Cell, donor5	11457-119A8	84.64	31.61
Bronchial Epithelial Cell, donor6	11461-119B3	33.62	26.02
Bronchial Epithelial Cell, donor7	11769-123I5	119.12	35.27
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.16	7.63
Burkitt's lymphoma cell line:RAJI	10476-106I8	10.48	113.42
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	83.78	36.77
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	20.68
CD14+ Monocytes, donor1	11224-116B9	3.94	15.78
CD14+ Monocytes, donor2	11305-117B9	0.93	8.91
CD14+ Monocytes, donor3	11381-118B4	0.88	12.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.79	14.15
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.54	24.64
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	17.75	15.12
CD14+ monocytes - mock treated, donor1	11863-125A9	0.87	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	1.51	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	0.71	6.16
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	3.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.83	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.74	4.46
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.39	2.74
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.71	3.74
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.74	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.23	2.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	4.22
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.04	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.60	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.21	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.46	2.97
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.68	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.87	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.54	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.87	4.01
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.84	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.73	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.70	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.44	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	2.79
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.49	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.65	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.44	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.46	2.78
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.23	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	0.22	9.15
CD14+CD16+ Monocytes, donor2	11801-124D1	0.69	11.55
CD14+CD16+ Monocytes, donor3	11912-125G4	0.65	8.45
CD14+CD16- Monocytes, donor1	11788-124B6	0.62	10.28
CD14+CD16- Monocytes, donor2	11799-124C8	0.87	5.59
CD14+CD16- Monocytes, donor3	11910-125G2	0.89	15.61
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	8.68
CD14-CD16+ Monocytes, donor2	11800-124C9	0.22	11.20
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	8.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	30.48
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	24.41
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	20.71
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.72	26.12
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.59	29.48
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	25.97	21.76
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	20.39	29.02
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	18.46	25.05
CD19+ B Cells, donor1	11544-120B5	14.79	34.52
CD19+ B Cells, donor2	11624-122B4	6.53	41.35
CD19+ B Cells, donor3	11705-123B4	17.16	39.38
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.44	8.08
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	6.39	3.60
CD34+ Progenitors, donor1	11545-120B6	53.21	13.05
CD34+ Progenitors, donor2	11625-122B5	34.27	8.43
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	92.06	31.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	106.88	36.98
CD4+ T Cells, donor1	11225-116C1	2.50	44.63
CD4+ T Cells, donor2	11306-117C1	1.84	30.01
CD4+ T Cells, donor3	11382-118B5	0.91	39.34
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.28	89.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.35	86.69
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.72	77.33
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.95	57.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	60.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	46.15
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	3.90	54.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.41	57.28
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.74	49.33
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.24	37.21
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.75	48.56
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	57.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.42	64.93
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1.04	55.89
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1.34	63.48
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	10.06	68.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	13.93	93.79
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	68.14
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1.67	75.28
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.08	53.72
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.63	48.55
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.53	47.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.90	47.22
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.92	66.24
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.44	54.44
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	5.54	56.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	27.92
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	6.37	61.76
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	13.50	70.43
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	4.62	66.22
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3.58	60.16
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	38.78
CD8+ T Cells, donor1	11226-116C2	2.95	54.02
CD8+ T Cells, donor2	11307-117C2	1.50	38.29
CD8+ T Cells, donor3	11383-118B6	4.54	48.73
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.18	33.49
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.39	26.60
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.40	35.02
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.51	39.33
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.44	28.32
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	36.61
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.43	34.33
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.69	36.06
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.13	36.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.98	41.96
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.11	42.41
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.12	40.76
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	24.95
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.76	30.51
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	44.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	13.33	27.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.65	33.38
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.31	33.70
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.77	39.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	36.29
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.34	34.30
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	35.19
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	32.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	34.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.85	20.88
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.19	23.08
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	45.08
Cardiac Myocyte, donor1	11525-119I4	312.54	56.66
Cardiac Myocyte, donor2	11605-120I3	311.28	41.50
Cardiac Myocyte, donor3	11686-122I3	327.69	35.78
Chondrocyte - de diff, donor1	11261-116G1	286.00	38.13
Chondrocyte - de diff, donor2	11338-117F6	255.52	47.98
Chondrocyte - de diff, donor3	11410-118E6	278.42	37.55
Chondrocyte - re diff, donor2	11339-117F7	636.53	68.04
Chondrocyte - re diff, donor3	11411-118E7	398.74	27.50
Ciliary Epithelial Cells, donor1	11242-116D9	342.55	77.81
Ciliary Epithelial Cells, donor2	11323-117D9	385.63	61.99
Ciliary Epithelial Cells, donor3	11399-118D4	430.19	61.86
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	186.61	87.30
Corneal Epithelial Cells, donor1	11526-119I5	97.71	49.40
Corneal Epithelial Cells, donor2	11606-120I4	73.94	63.71
Corneal Epithelial Cells, donor3	11687-122I4	66.46	57.52
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	7.59	7.59
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.68	11.35
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.94	10.47
Dendritic Cells - plasmacytoid, donor1	11228-116C4	97.03	17.42
Dendritic Cells - plasmacytoid, donor2	11309-117C4	81.61	7.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	115.18	11.13
Endothelial Cells - Aortic, donor0	11207-116A1	164.93	23.35
Endothelial Cells - Aortic, donor1	11263-116G3	159.60	20.54
Endothelial Cells - Aortic, donor2	11340-117F8	311.08	26.58
Endothelial Cells - Aortic, donor3	11412-118E8	208.78	18.48
Endothelial Cells - Artery, donor1	11264-116G4	210.01	13.38
Endothelial Cells - Artery, donor2	11341-117F9	255.51	16.47
Endothelial Cells - Artery, donor3	11413-118E9	252.09	20.34
Endothelial Cells - Lymphatic, donor1	11236-116D3	205.25	11.75
Endothelial Cells - Lymphatic, donor2	11317-117D3	259.24	15.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	293.74	16.63
Endothelial Cells - Microvascular, donor1	11265-116G5	125.69	14.26
Endothelial Cells - Microvascular, donor2	11342-117G1	183.27	22.39
Endothelial Cells - Microvascular, donor3	11414-118F1	126.62	15.45
Endothelial Cells - Thoracic, donor1	11266-116G6	195.26	23.61
Endothelial Cells - Thoracic, donor2	11343-117G2	309.23	15.72
Endothelial Cells - Umbilical vein, donor1	11243-116E1	302.29	43.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	211.40	32.37
Endothelial Cells - Umbilical vein, donor3	11400-118D5	218.24	34.07
Endothelial Cells - Vein, donor1	11267-116G7	162.66	14.79
Endothelial Cells - Vein, donor2	11344-117G3	266.13	31.43
Endothelial Cells - Vein, donor3	11416-118F3	222.16	26.38
Eosinophils, donor1	12244-129H3	0.00	76.23
Eosinophils, donor2	12245-129H4	0.00	1.65
Eosinophils, donor3	12246-129H5	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	106.28	43.49
Esophageal Epithelial Cells, donor2	11587-120G3	70.73	33.28
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	453.21	45.57
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	200.47	22.45
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	166.62	17.01
Fibroblast - Aortic Adventitial, donor1	11245-116E3	369.54	35.66
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	666.53	97.85
Fibroblast - Aortic Adventitial, donor2	11326-117E3	393.72	37.13
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	741.20	89.85
Fibroblast - Aortic Adventitial, donor3	11401-118D6	362.10	39.86
Fibroblast - Cardiac, donor1	11268-116G8	394.20	47.18
Fibroblast - Cardiac, donor2	11345-117G4	452.50	36.38
Fibroblast - Cardiac, donor3	11417-118F4	349.18	32.80
Fibroblast - Cardiac, donor4	11452-119A3	506.49	77.90
Fibroblast - Cardiac, donor5	11456-119A7	199.11	26.78
Fibroblast - Cardiac, donor6	11460-119B2	219.81	27.59
Fibroblast - Choroid Plexus, donor1	11492-119E7	1052.90	94.60
Fibroblast - Choroid Plexus, donor2	11572-120E6	476.73	55.65
Fibroblast - Choroid Plexus, donor3	11653-122E6	383.78	48.34
Fibroblast - Conjunctival, donor1	11531-120A1	256.93	69.19
Fibroblast - Conjunctival, donor3	11692-122I9	361.43	57.84
Fibroblast - Dermal, donor1	11269-116G9	206.61	44.84
Fibroblast - Dermal, donor2	11346-117G5	207.07	49.53
Fibroblast - Dermal, donor3	11418-118F5	169.97	38.68
Fibroblast - Dermal, donor4	11450-119A1	247.91	46.80
Fibroblast - Dermal, donor5	11454-119A5	236.04	47.80
Fibroblast - Dermal, donor6	11458-119A9	306.82	59.28
Fibroblast - Gingival, donor1	11237-116D4	450.82	66.63
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	618.84	72.84
Fibroblast - Gingival, donor2	11318-117D4	312.20	58.12
Fibroblast - Gingival, donor3	11394-118C8	306.69	52.02
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	249.33	54.02
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	233.12	27.31
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	539.56	63.45
Fibroblast - Gingival, donor6 (control)	11922-125H5	433.40	55.04
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	480.27	53.28
Fibroblast - Gingival, donor7 (control)	11924-125H7	766.61	72.54
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	694.86	61.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	421.44	52.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	400.01	52.97
Fibroblast - Lung, donor1	11270-116H1	273.23	57.09
Fibroblast - Lung, donor2	11347-117G6	235.76	43.27
Fibroblast - Lung, donor3	11419-118F6	290.39	50.86
Fibroblast - Lymphatic, donor1	11506-119G3	1104.59	149.94
Fibroblast - Lymphatic, donor2	11586-120G2	542.67	57.34
Fibroblast - Lymphatic, donor3	11667-122G2	390.99	53.74
Fibroblast - Mammary, donor1	11540-120B1	888.67	146.15
Fibroblast - Mammary, donor2	11620-122A9	527.24	99.86
Fibroblast - Mammary, donor3	11701-123A9	750.49	77.43
Fibroblast - Periodontal Ligament, donor1	11238-116D5	319.09	53.92
Fibroblast - Periodontal Ligament, donor2	11319-117D5	448.22	70.84
Fibroblast - Periodontal Ligament, donor3	11395-118C9	442.76	63.65
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	468.63	50.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	428.74	37.80
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	244.82	34.21
Fibroblast - Pulmonary Artery, donor1	11250-116E8	227.70	22.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	751.40	115.62
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	465.74	73.50
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	357.01	49.42
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1414.14	118.08
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	389.52	36.59
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	328.54	31.93
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	861.95	89.35
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	532.96	46.20
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1388.11	103.25
Fibroblast - skin normal, donor1	11553-120C5	623.82	45.45
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	605.93	95.04
Fibroblast - skin normal, donor2	11561-120D4	510.25	40.18
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	1379.71	139.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	374.22	42.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	553.20	51.29
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1508.82	127.10
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	552.85	35.26
Fibroblast - skin walker warburg, donor1	11554-120C6	417.15	39.98
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	238.37	19.92
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	67.98	38.35
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	78.18	19.76
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	119.71	18.74
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	100.16	27.34
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	186.79	78.09
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	156.33	87.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	152.33	75.59
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	411.71	179.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	260.52	124.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	174.55	95.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	305.57	154.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	262.22	127.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	114.54	65.01
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	354.72	151.07
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	370.90	146.91
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	280.71	138.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	302.55	110.02
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	222.73	113.92
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	188.67	107.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	405.47	102.45
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	245.39	97.04
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	281.31	78.03
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	463.02	124.10
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	390.56	137.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	432.09	92.50
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	521.22	131.47
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	461.43	142.16
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	530.79	136.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	661.80	163.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	654.41	152.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	474.04	148.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	484.12	112.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	537.81	112.30
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	562.60	121.51
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	512.02	133.97
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	450.60	120.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	549.53	118.81
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	547.68	147.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	546.90	124.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	592.36	124.44
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	411.14	117.31
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	449.38	100.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	506.00	135.62
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	436.76	126.07
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	498.17	106.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	552.40	123.16
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	338.04	103.14
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	463.41	106.43
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	390.78	88.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	409.98	99.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	625.09	113.58
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	762.11	119.64
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	725.05	113.38
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1160.34	209.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	850.44	98.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	744.89	91.80
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1905.69	212.48
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	254.80	138.35
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	249.30	146.37
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	290.71	228.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	164.91	64.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	139.02	48.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	119.45	76.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	111.37	91.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	211.97	69.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	255.11	78.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	140.85	92.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	219.05	54.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	238.84	71.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	203.27	109.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	277.69	69.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	289.26	65.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	224.81	93.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	316.48	71.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	328.79	69.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	225.52	48.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	319.57	78.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	381.82	72.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	264.29	60.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	451.90	81.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	362.68	88.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	247.62	47.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	314.83	60.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	404.86	56.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	259.51	39.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	419.94	61.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	601.83	77.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	260.90	32.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	417.12	62.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	426.67	50.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	339.80	72.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	331.43	68.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	410.47	64.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	388.37	62.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	337.23	54.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	506.47	43.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	370.44	49.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	296.67	50.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	330.45	70.36
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	488.48	55.92
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	593.37	50.73
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	443.03	33.73
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	347.29	33.94
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	324.17	29.66
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.00	35.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.00	36.29
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.00	36.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.00	38.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.00	27.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.00	26.91
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.00	32.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.00	29.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	28.19
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	237.28	19.03
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	396.44	47.17
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	248.52	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	804.91	76.19
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	791.17	78.46
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	285.51	32.35
Hepatocyte, donor1	11523-119I2	95.64	48.42
Hepatocyte, donor2	11603-120I1	135.74	45.25
Hepatocyte, donor3	11684-122I1	83.44	29.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	98.56	32.63
Intestinal epithelial cells (polarized), donor1	11246-116E4	329.29	17.65
Iris Pigment Epithelial Cells, donor1	11530-119I9	327.24	49.12
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	44.57
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	26.70
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	35.99
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	20.02
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	59.34
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	23.07
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	50.28
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	37.36
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	38.35
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	42.35
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	21.06
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	47.14
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	34.01
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	29.39
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	36.82
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	14.49
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	39.11
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	24.77
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	31.34
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	29.55
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	33.04
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	29.02
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	27.98
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	22.87
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	40.81
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	21.87
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	42.84
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	33.18
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	39.20
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	49.17
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	31.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	42.42
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	44.26
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	29.18
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	46.21
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	47.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	48.78
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	44.80
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	34.64
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	19.95
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	28.53
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	21.18
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	31.72
Keratinocyte - epidermal, donor1	11272-116H3	148.51	49.86
Keratinocyte - epidermal, donor2	11349-117G8	21.08	25.18
Keratinocyte - epidermal, donor3	11421-118F8	58.12	30.20
Keratinocyte - oral, donor1	11251-116E9	161.88	63.57
Keratocytes, donor1	11527-119I6	123.44	63.26
Keratocytes, donor2	11607-120I5	404.27	60.93
Keratocytes, donor3	11688-122I5	119.74	36.75
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	63.74
Lens Epithelial Cells, donor1	11529-119I8	245.95	36.68
Lens Epithelial Cells, donor2	11609-120I7	282.10	61.70
Lens Epithelial Cells, donor3	11690-122I7	670.34	67.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	106.96	22.06
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	84.28	13.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	91.61	17.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	88.72	15.59
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	91.71	20.80
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	94.77	18.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	77.97	15.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	83.43	17.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	100.78	17.59
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	68.03	20.57
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	84.92	18.81
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	96.09	18.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	94.77	21.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	93.02	17.65
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	90.92	21.01
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	87.77	17.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	89.16	18.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	115.65	19.21
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	84.58	19.75
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	96.94	23.43
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	118.99	22.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	81.96	12.12
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	79.17	18.31
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	102.79	21.95
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	82.95	20.74
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	77.06	14.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	100.15	21.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	76.35	19.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	79.02	15.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	99.24	20.04
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	65.90	16.96
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	72.77	14.22
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	95.03	23.29
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	104.03	23.32
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	70.91	17.05
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	103.67	19.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	87.16	18.33
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	78.21	18.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	93.36	16.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	79.65	16.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	94.05	14.06
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	98.66	17.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	78.78	15.04
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	92.45	17.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	96.99	19.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	95.04	26.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	66.59	16.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	96.97	16.41
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	27.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	82.08	28.38
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	95.01	20.04
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	96.47	23.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	106.20	21.80
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	90.59	16.81
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	94.29	27.31
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	103.48	27.36
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	87.54	20.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	82.89	19.19
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	78.78	17.11
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	124.65	26.69
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	91.41	22.60
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	84.69	15.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	75.96	21.32
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	103.41	22.41
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	91.51	21.88
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	98.25	26.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.13	19.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	129.65	12.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	95.79	21.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	89.12	20.74
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	105.09	19.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	101.03	24.68
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	78.32	20.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	89.07	22.13
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	122.66	22.62
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	100.68	15.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	73.68	12.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	110.14	23.79
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	107.00	24.91
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	105.84	25.43
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	115.68	24.40
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	104.85	19.39
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	115.77	26.89
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	109.25	26.38
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	86.58	19.81
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	94.19	24.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	101.29	24.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	105.58	19.31
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	111.63	22.75
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	110.33	16.84
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	106.28	30.59
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	111.10	23.57
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	120.01	19.26
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	61.64	15.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	79.33	19.04
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	136.85	22.01
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	105.40	18.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	104.25	19.93
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	111.97	30.58
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	86.57	18.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	110.12	20.11
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	114.91	23.43
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	99.82	13.77
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	113.12	28.50
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	116.53	19.16
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	96.32	17.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	113.13	24.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	114.64	22.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	87.78	21.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	108.20	19.43
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	97.20	21.99
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	88.61	21.27
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	105.74	18.26
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	108.93	22.26
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	86.89	18.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	84.39	17.29
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	97.28	22.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	76.95	18.59
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	84.65	15.12
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	125.81	26.94
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	102.89	19.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	88.50	20.11
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	111.59	18.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	104.69	32.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	102.72	17.02
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	129.38	22.88
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	104.93	25.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	101.46	19.62
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	106.87	23.23
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	84.97	21.41
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	102.12	20.85
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	104.26	18.99
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	90.86	15.60
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	120.03	20.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	114.54	27.35
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	88.96	24.54
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	126.40	22.98
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	106.91	23.61
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	106.58	20.02
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	106.10	14.59
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	149.66	31.18
Macrophage - monocyte derived, donor1	11232-116C8	19.14	8.66
Macrophage - monocyte derived, donor2	11313-117C8	22.94	7.16
Macrophage - monocyte derived, donor3	11389-118C3	21.89	9.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	60.01	16.46
Mallassez-derived cells, donor2	11929-125I3	225.79	29.31
Mallassez-derived cells, donor3	11930-125I4	148.16	27.66
Mammary Epithelial Cell, donor1	11273-116H4	42.45	40.65
Mammary Epithelial Cell, donor2	11350-117G9	41.12	48.93
Mammary Epithelial Cell, donor3	11422-118F9	56.12	28.68
Mast cell - stimulated, donor1	11487-119E2	30.51	115.25
Mast cell, donor1	11563-120D6	3.68	44.99
Mast cell, donor2	11565-120D8	37.15	22.29
Mast cell, donor3	11566-120D9	71.81	23.41
Mast cell, donor4	11567-120E1	17.91	20.03
Mast cell, expanded and stimulated, donor5	11940-126A5	8.10	59.55
Mast cell, expanded and stimulated, donor8	11942-126A7	1.75	35.60
Mast cell, expanded, donor5	11939-126A4	1.61	35.45
Mast cell, expanded, donor8	11941-126A6	1.00	38.83
Melanocyte - dark, donor1	11502-119F8	117.01	17.91
Melanocyte - dark, donor2	11582-120F7	317.70	53.64
Melanocyte - dark, donor3	11663-122F7	99.39	40.64
Melanocyte - light, donor1	11274-116H5	116.83	41.14
Melanocyte - light, donor2	11351-117H1	99.64	39.58
Melanocyte - light, donor3	11423-118G1	104.07	23.42
Melanocyte, donor1 (MC+1)	12641-134G4	85.70	30.40
Melanocyte, donor2 (MC+2)	12739-135I3	143.62	21.52
Melanocyte, donor3 (MC+3)	12837-137B2	132.05	50.09
Meningeal Cells, donor1	11493-119E8	545.24	99.87
Meningeal Cells, donor2	11573-120E7	670.34	87.15
Meningeal Cells, donor3	11654-122E7	294.14	58.68
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	394.37	45.05
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	352.82	60.18
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	291.74	67.02
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	358.44	52.33
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	240.40	35.16
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	368.48	58.45
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	397.09	62.33
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	585.42	65.71
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	408.40	50.41
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	454.22	45.83
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	472.03	35.60
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	552.01	79.92
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	478.67	46.31
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	651.34	80.42
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	298.95	67.73
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	729.42	94.14
Mesenchymal stem cells - adipose, donor0	11217-116B2	197.07	34.03
Mesenchymal stem cells - hepatic, donor0	11218-116B3	353.38	31.59
Mesenchymal stem cells - umbilical, donor0	11214-116A8	279.39	34.11
Mesothelial Cells, donor1	11247-116E5	213.73	40.84
Mesothelial Cells, donor2	12156-128G5	259.24	33.53
Mesothelial Cells, donor3	11402-118D7	325.48	40.03
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	36.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.96	19.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.14	32.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	14.57
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.52	21.99
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.03	14.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.20	35.38
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.29	17.27
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.86	24.95
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	7.08
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	23.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.67	12.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	21.18
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.01	9.54
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	13.41
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.29	14.05
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.69	20.44
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	8.06
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	16.83	23.77
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.03	16.71
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	11.37
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.78	23.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	14.24
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	17.74
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.14	12.23
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.53	19.12
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	6.54
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	10.57
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.21	17.61
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	9.60
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	9.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	53.89
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.13	8.32
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	20.97
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	20.49
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.44	12.15
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	11.83
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	11.05
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.86	8.55
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.19	17.07
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	12.43
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.29	13.19
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	9.14
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	11.07
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.32	10.26
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	14.61
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	12.01
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.69	30.73
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.70	16.44
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.22	11.14
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.29	25.31
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	13.97
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.40	10.41
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.68	22.15
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.39	12.15
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.82	11.78
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.41	24.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	12.13
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.68	10.51
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.15	19.42
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	11.73
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	4.12	7.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	6.92	12.69
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.83	13.60
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.98	5.36
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.80	15.44
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	14.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.30	10.87
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	16.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	13.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.45	11.19
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.66	7.35
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	10.31
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.89	18.69
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	17.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	19.19
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.75	10.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	408.47	41.79
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	383.07	50.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	334.41	110.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	362.28	51.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	390.17	61.42
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	623.98	78.20
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	205.34	57.12
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	187.44	11.03
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	244.84	59.01
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	335.41	56.25
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	334.81	121.87
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	356.98	77.79
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	354.89	53.61
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	250.10	34.38
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	291.97	57.12
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	257.36	60.42
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	325.69	55.41
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	253.55	54.10
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	252.73	45.62
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	483.08	63.01
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	243.77	53.18
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	354.88	58.21
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	196.20	46.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	270.77	39.08
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	271.86	59.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	400.42	44.49
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	490.52	27.81
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	276.25	48.79
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	225.24	38.53
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	229.99	27.53
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	275.58	51.94
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	207.64	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	285.57	65.98
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	468.00	48.69
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	219.03	34.92
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	192.23	53.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	307.62	40.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	304.05	43.02
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	224.43	76.70
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	561.29	48.85
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	272.51	57.32
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	196.13	33.24
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	222.23	61.01
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	341.86	51.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	339.65	49.90
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	499.96	49.73
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	212.78	38.63
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	153.29	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	269.48	54.87
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	474.62	47.84
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	300.53	62.95
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	287.18	56.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	395.64	26.07
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	161.85	5.06
Myoblast, donor1	11241-116D8	358.52	32.42
Myoblast, donor2	11322-117D8	471.03	55.81
Myoblast, donor3	11398-118D3	358.86	35.99
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	78.66
Natural Killer Cells, donor1	11230-116C6	1.54	56.58
Natural Killer Cells, donor2	11311-117C6	1.21	34.08
Natural Killer Cells, donor3	11387-118C1	1.66	42.15
Neural stem cells, donor1	11275-116H6	526.63	125.21
Neural stem cells, donor2	11352-117H2	518.00	107.84
Neurons, donor1	11494-119E9	316.34	64.86
Neurons, donor2	11574-120E8	286.43	79.04
Neurons, donor3	11655-122E8	207.19	82.22
Neutrophils, donor1	11233-116C9	0.00	1.86
Neutrophils, donor2	11314-117C9	2.90	2.90
Neutrophils, donor3	11390-118C4	0.00	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	526.47	76.11
Nucleus Pulposus Cell, donor2	11409-118E5	522.92	58.61
Nucleus Pulposus Cell, donor3	11462-119B4	240.06	35.30
Olfactory epithelial cells, donor1	11933-125I7	349.91	41.57
Olfactory epithelial cells, donor2	11934-125I8	352.74	50.81
Olfactory epithelial cells, donor3	11935-125I9	324.51	50.40
Olfactory epithelial cells, donor4	11936-126A1	363.88	41.69
Oligodendrocyte - precursors, donor1	11496-119F2	315.96	33.70
Osteoblast - differentiated, donor1	11276-116H7	408.80	48.07
Osteoblast - differentiated, donor2	11353-117H3	138.32	18.29
Osteoblast - differentiated, donor3	11425-118G3	122.28	24.21
Osteoblast, donor1	11277-116H8	655.10	96.16
Osteoblast, donor2	11354-117H4	520.42	58.29
Osteoblast, donor3	11426-118G4	531.77	46.03
Pancreatic stromal cells, donor1	11249-116E7	297.94	51.30
Pericytes, donor1	11491-119E6	504.48	85.90
Pericytes, donor2	11571-120E5	581.76	61.35
Pericytes, donor3	11652-122E5	547.89	52.08
Perineurial Cells, donor1	11499-119F5	395.80	50.41
Perineurial Cells, donor2	11579-120F4	366.39	58.24
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.10	46.85
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	2.45	26.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.27	32.48
Placental Epithelial Cells, donor1	11278-116H9	161.68	33.48
Placental Epithelial Cells, donor2	11355-117H5	489.02	38.81
Placental Epithelial Cells, donor3	11427-118G5	498.08	60.47
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	272.78	15.51
Preadipocyte - breast, donor1	11467-119B9	352.10	31.33
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1011.59	75.31
Preadipocyte - breast, donor2	11328-117E5	444.44	31.75
Preadipocyte - omental, donor1	11468-119C1	392.88	41.77
Preadipocyte - omental, donor2	11329-117E6	442.58	36.66
Preadipocyte - omental, donor3	11403-118D8	502.37	41.69
Preadipocyte - perirenal, donor1	11469-119C2	476.39	28.54
Preadipocyte - subcutaneous, donor1	11279-116I1	553.43	54.97
Preadipocyte - subcutaneous, donor2	11356-117H6	424.63	46.39
Preadipocyte - subcutaneous, donor3	11428-118G6	424.52	45.30
Preadipocyte - visceral, donor1	11280-116I2	491.91	65.11
Preadipocyte - visceral, donor2	11357-117H7	496.99	59.82
Preadipocyte - visceral, donor3	11429-118G7	355.69	36.99
Prostate Epithelial Cells (polarized), donor1	11253-116F2	208.63	23.53
Prostate Epithelial Cells, donor2	11331-117E8	223.70	28.71
Prostate Epithelial Cells, donor3	11404-118D9	15.80	19.23
Prostate Stromal Cells, donor1	11254-116F3	380.20	39.98
Prostate Stromal Cells, donor2	11332-117E9	433.90	35.14
Prostate Stromal Cells, donor3	11405-118E1	354.64	40.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	128.84	53.29
Renal Cortical Epithelial Cells, donor2	11596-120H3	94.26	35.90
Renal Epithelial Cells, donor1	11517-119H5	207.46	62.90
Renal Epithelial Cells, donor2	11597-120H4	155.07	65.44
Renal Epithelial Cells, donor3	11678-122H4	134.55	50.18
Renal Glomerular Endothelial Cells, donor1	11514-119H2	206.30	19.06
Renal Glomerular Endothelial Cells, donor2	11594-120H1	201.34	15.63
Renal Glomerular Endothelial Cells, donor3	11675-122H1	228.01	23.98
Renal Glomerular Endothelial Cells, donor4	11783-124B1	267.51	29.94
Renal Mesangial Cells, donor1	11518-119H6	400.34	85.17
Renal Mesangial Cells, donor2	11598-120H5	381.21	72.73
Renal Mesangial Cells, donor3	11679-122H5	269.37	66.02
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	80.26	42.14
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	58.62	34.58
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	158.71	58.43
Retinal Pigment Epithelial Cells, donor0	11215-116A9	276.14	75.45
Retinal Pigment Epithelial Cells, donor1	11528-119I7	451.95	105.74
Retinal Pigment Epithelial Cells, donor2	11608-120I6	374.60	61.75
Retinal Pigment Epithelial Cells, donor3	11689-122I6	105.13	68.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	154.62	32.61
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	238.54	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	251.52	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	233.76	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	453.53	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	418.18	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	432.33	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	328.71	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	440.07	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	452.09	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	391.28	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	373.34	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	334.91	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	374.28	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	388.48	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	389.88	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	381.21	3.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	377.40	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	492.69	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	375.03	5.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	396.57	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	392.99	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	381.47	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	366.08	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	443.31	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	359.74	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	418.67	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	408.74	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	434.24	4.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	434.33	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	400.58	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	391.69	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	426.27	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	419.86	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	443.32	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	378.22	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	401.59	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	456.32	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	395.18	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	375.78	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	445.51	6.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	513.86	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	387.03	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	361.29	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	411.68	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	553.43	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	284.59	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	332.59	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	327.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	260.32	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	273.06	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	267.71	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	248.35	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	371.63	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	425.05	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	322.34	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	311.84	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	292.68	3.00
Schwann Cells, donor1	11498-119F4	419.77	66.58
Schwann Cells, donor2	11578-120F3	176.93	37.43
Schwann Cells, donor3	11659-122F3	372.00	47.98
Sebocyte, donor1	11220-116B5	309.49	78.88
Sebocyte, donor2	11301-117B5	148.44	66.18
Sebocyte, donor3	11378-118B1	268.56	74.20
Sertoli Cells, donor1	11255-116F4	356.17	34.79
Sertoli Cells, donor2	11333-117F1	316.33	31.07
Skeletal Muscle Cells, donor1	11281-116I3	190.47	46.10
Skeletal Muscle Cells, donor2	11358-117H8	209.62	15.90
Skeletal Muscle Cells, donor3	11430-118G8	550.11	56.01
Skeletal Muscle Cells, donor4	11451-119A2	282.93	43.20
Skeletal Muscle Cells, donor5	11455-119A6	306.95	48.31
Skeletal Muscle Cells, donor6	11459-119B1	248.24	47.71
Skeletal Muscle Satellite Cells, donor1	11240-116D7	553.92	70.56
Skeletal Muscle Satellite Cells, donor2	11321-117D7	602.43	62.64
Skeletal Muscle Satellite Cells, donor3	11397-118D2	321.14	52.98
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	615.80	64.71
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	228.71	31.85
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	471.83	48.02
Skin - palm, donor1	10286-104F7	51.04	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	94.71	25.52
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	182.39	157.04
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	62.84	29.08
Small Airway Epithelial Cells, donor1	11256-116F5	54.21	19.32
Small Airway Epithelial Cells, donor2	11334-117F2	55.42	19.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	93.04	86.27
Small Airway Epithelial Cells, donor3	11406-118E2	31.70	17.69
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	276.18	21.29
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1271.51	126.06
Smooth Muscle Cells - Aortic, donor0	11210-116A4	529.63	50.55
Smooth Muscle Cells - Aortic, donor1	11283-116I5	430.27	40.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	483.56	50.80
Smooth Muscle Cells - Aortic, donor3	11432-118H1	559.34	55.62
Smooth Muscle Cells - Bladder, donor1	11519-119H7	221.17	69.05
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	470.03	59.62
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	440.65	46.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	213.94	15.75
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	361.73	42.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	395.15	48.43
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	367.01	32.46
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	472.90	60.84
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	163.48	42.62
Smooth Muscle Cells - Carotid, donor1	11285-116I7	544.53	63.14
Smooth Muscle Cells - Carotid, donor2	11362-117I3	777.33	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	288.01	28.13
Smooth Muscle Cells - Colonic, donor1	11239-116D6	350.99	43.21
Smooth Muscle Cells - Colonic, donor2	11320-117D6	474.60	53.38
Smooth Muscle Cells - Colonic, donor3	11396-118D1	422.04	50.06
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	576.64	59.09
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	460.25	24.79
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	262.99	23.91
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	559.21	78.18
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	428.77	51.04
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	606.77	88.87
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	300.37	27.76
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	409.38	40.46
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	240.55	41.86
Smooth Muscle Cells - Prostate, donor1	11257-116F6	418.65	41.15
Smooth Muscle Cells - Prostate, donor2	11335-117F3	498.50	48.08
Smooth Muscle Cells - Prostate, donor3	11465-119B7	265.33	33.99
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	538.56	54.28
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	399.84	30.01
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	669.37	28.43
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	798.53	62.32
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	488.22	46.45
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	330.00	30.09
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	474.65	46.90
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	382.13	54.07
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	468.56	51.39
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	423.55	45.48
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	358.98	27.79
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	345.42	32.72
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	423.43	53.80
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	348.89	49.60
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	319.04	25.24
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	426.69	38.17
Smooth Muscle Cells - Uterine, donor1	11258-116F7	484.54	47.28
Smooth Muscle Cells - Uterine, donor3	11466-119B8	190.18	29.84
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	325.75	47.81
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	323.96	46.01
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	308.34	56.16
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	381.62	45.28
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	275.95	42.02
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	332.82	40.17
Smooth muscle cells - airway, control, donor1	11966-126D4	287.47	48.76
Smooth muscle cells - airway, control, donor2	11967-126D5	286.31	37.14
Smooth muscle cells - airway, control, donor3	11968-126D6	214.02	32.19
Smooth muscle cells - airway, control, donor4	11969-126D7	231.93	39.88
Synoviocyte, donor1	11291-117A4	401.95	43.09
Synoviocyte, donor2	11368-117I9	160.75	27.49
Synoviocyte, donor3	11440-118H9	124.66	26.81
Trabecular Meshwork Cells, donor1	11532-120A2	565.66	115.78
Trabecular Meshwork Cells, donor2	11612-122A1	237.84	65.41
Trabecular Meshwork Cells, donor3	11693-123A1	498.98	76.64
Tracheal Epithelial Cells, donor1	11292-117A5	52.40	28.53
Tracheal Epithelial Cells, donor2	11369-118A1	87.75	27.83
Tracheal Epithelial Cells, donor3	11441-118I1	61.27	17.75
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	155.99	27.43
Urethra, donor2	10319-105A4	138.48	53.95
Urothelial Cells, donor1	11520-119H8	166.04	44.10
Urothelial Cells, donor2	11600-120H7	98.94	48.87
Urothelial Cells, donor3	11681-122H7	120.56	34.15
Urothelial cells, donor0	11216-116B1	189.02	39.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.89	25.80
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	28.59
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.74	20.54
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.82	32.71
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.07	35.44
Whole blood (ribopure), donor090612, donation1	12182-129A4	2.08	20.82
Whole blood (ribopure), donor090612, donation2	12183-129A5	1.84	37.63
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	25.56
Wilms' tumor cell line:G-401	10809-111A8	129.16	84.01
Wilms' tumor cell line:HFWT	10597-108E3	106.48	80.96
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	81.84	1.12
achilles tendon, donor2	10292-104G4	64.06	20.67
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	130.28	87.70
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	230.08	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	235.52	169.16
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	149.12	59.05
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.54	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	83.02	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	133.07	13.66
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	233.17	23.68
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	90.71
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.90	63.67
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	122.55	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.07	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.40	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.85	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	181.75
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	116.74	58.70
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	286.16	107.78
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	79.85
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	5.67	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	196.82	123.71
adenocarcinoma cell line:IM95m	10796-110I4	0.00	138.24
adipose tissue, adult, pool1	10010-101C1	40.02	17.99
adipose, donor1	10184-103D4	460.92	110.83
adipose, donor2	10185-103D5	219.39	109.90
adipose, donor3	10186-103D6	241.52	103.74
adipose, donor4	10187-103D7	442.91	50.27
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	372.46	169.66
adrenal gland, adult, pool1	10081-102A9	163.70	112.77
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	37.22
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.88	57.88
amniotic membrane cells, donor1	12235-129G3	197.07	25.04
amniotic membrane cells, donor2	12236-129G4	628.20	41.92
amniotic membrane cells, donor3	12237-129G5	186.19	27.69
amygdala - adult, donor10196	10167-103B5	379.46	198.03
amygdala, adult, donor10252	10151-102I7	219.19	99.15
amygdala, newborn, donor10223	10360-105E9	254.34	128.46
anaplastic carcinoma cell line:8305C	10428-106D5	523.20	52.59
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	221.47	82.84
aorta, adult, pool1	10052-101G7	117.68	29.81
appendix, adult	10189-103D9	47.74	80.34
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	100.77	36.46
artery, adult	10190-103E1	55.71	31.25
astrocytoma cell line:TM-31	10425-106D2	242.94	45.78
b cell line:RPMI1788	10427-106D4	176.66	34.80
basal cell carcinoma cell line:TE 354.T	10702-109G9	397.03	24.14
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.69	34.63
bile duct carcinoma cell line:TFK-1	10496-107C1	32.47	39.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	21.25
bladder, adult, pool1	10011-101C2	90.72	34.55
blood, adult, pool1	10053-101G8	6.64	24.36
bone marrow stromal cell line:StromaNKtert	10686-109F2	634.55	29.97
bone marrow, adult	10192-103E3	410.97	59.38
brain, adult, donor1	10084-102B3	140.43	141.46
brain, adult, pool1	10012-101C3	225.83	135.63
brain, fetal, pool1	10085-102B4	550.31	211.04
breast carcinoma cell line:MCF7	10482-107A5	57.48	27.75
breast carcinoma cell line:MDA-MB-453	10419-106C5	443.37	55.17
breast, adult, donor1	10080-102A8	22.73	12.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.24	67.08
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	213.98	119.67
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	121.33	9.67
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	245.90	18.34
carcinoid cell line:NCI-H727	10735-110B6	391.69	45.17
carcinoid cell line:SK-PN-DW	10719-109I8	501.33	68.13
carcinosarcoma cell line:JHUCS-1	10642-109A3	229.98	0.27
caudate nucleus - adult, donor10196	10177-103C6	203.78	165.79
caudate nucleus, adult, donor10252	10164-103B2	234.76	94.71
caudate nucleus, adult, donor10258	10379-105H1	269.74	178.81
caudate nucleus, newborn, donor10223	10354-105E3	226.33	107.67
cerebellum - adult, donor10196	10173-103C2	215.58	247.63
cerebellum, adult, donor10252	10166-103B4	160.35	164.62
cerebellum, adult, pool1	10083-102B2	122.46	104.17
cerebellum, newborn, donor10223	10357-105E6	250.75	170.21
cerebral meninges, adult	10188-103D8	160.36	74.63
cerebrospinal fluid, donor2	10294-104G6	46.05	27.77
cervical cancer cell line:D98-AH2	10552-107I3	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	23.86	41.93
cervix, adult, pool1	10013-101C4	230.98	41.79
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	169.44	15.61
chondrosarcoma cell line:SW 1353	10700-109G7	195.94	22.21
choriocarcinoma cell line:BeWo	10423-106C9	400.04	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.12	62.84
choriocarcinoma cell line:T3M-3	10618-108G6	181.20	69.49
chorionic membrane cells, donor1	12238-129G6	282.93	13.96
chorionic membrane cells, donor2	12239-129G7	587.54	41.16
chorionic membrane cells, donor3	12240-129G8	334.09	7.14
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	80.78	19.19
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.93	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	17.95	42.87
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	37.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	53.46
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.20	50.29
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	58.60
chronic myelogenous leukemia cell line:KU812	10409-106B4	16.68	77.41
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.26	103.32
clear cell carcinoma cell line:TEN	10636-108I6	205.43	15.62
colon carcinoma cell line:CACO-2	10513-107D9	286.46	27.27
colon carcinoma cell line:COLO-320	10420-106C6	636.64	0.00
colon, adult, donor1	10082-102B1	54.74	105.91
colon, adult, pool1	10014-101C5	48.29	52.52
colon, fetal, donor1	10070-101I7	50.06	56.85
common myeloid progenitor CMP, donor1	12130-128D6	91.67	9.17
common myeloid progenitor CMP, donor2	12134-128E1	75.11	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.15	95.61
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.68	70.64
cord blood derived cell line:COBL-a untreated	10449-106F8	34.12	77.84
corpus callosum, adult, pool1	10042-101F6	218.36	83.70
cruciate ligament, donor2	10295-104G7	61.60	29.99
diaphragm, fetal, donor1	10069-101I6	152.49	44.14
diencephalon, adult	10193-103E4	145.91	78.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.15	118.94
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.39	71.55
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	98.94	28.16
ductus deferens, adult	10196-103E7	294.52	49.34
duodenum, fetal, donor1, tech_rep1	10071-101I8	180.03	64.81
duodenum, fetal, donor1, tech_rep2	10071-101I8	273.66	57.38
dura mater, adult, donor1	10041-101F5	232.07	43.44
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	36.64	80.17
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	98.16	81.96
embryonic pancreas cell line:1B2C6	10604-108F1	64.13	22.20
embryonic pancreas cell line:1C3D3	10605-108F2	53.88	38.14
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.65	31.18
embryonic pancreas cell line:2C6	10603-108E9	61.73	26.27
endometrial carcinoma cell line:OMC-2	10497-107C2	173.97	71.40
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	112.00	51.11
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	123.67	22.03
epidermoid carcinoma cell line:A431	10426-106D3	55.02	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.66	0.00
epididymis, adult	10197-103E8	519.09	65.31
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	283.15	2.84
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	73.54	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.13	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.00	0.00
esophagus, adult, pool1	10015-101C6	55.42	28.99
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	335.38	117.47
eye - muscle inferior rectus, donor1	10272-104E2	45.88	41.05
eye - muscle lateral, donor2	10298-104H1	44.19	50.50
eye - muscle medial, donor2	10299-104H2	77.39	77.39
eye - muscle superior, donor2	10297-104G9	60.76	41.27
eye - vitreous humor, donor1	10268-104D7	46.64	8.74
eye, fetal, donor1	10054-101G9	214.57	63.05
fibrosarcoma cell line:HT-1080	10758-110E2	32.44	37.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.88	11.16
frontal lobe, adult, pool1	10040-101F4	253.79	172.82
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	69.36	52.24
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	355.14	85.13
gall bladder, adult	10198-103E9	165.86	52.87
gamma delta positive T cells, donor1	11937-126A2	4.83	61.74
gamma delta positive T cells, donor2	11938-126A3	8.96	58.26
gastric adenocarcinoma cell line:MKN1	10614-108G2	76.67	50.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	60.93	50.87
gastric cancer cell line:AZ521	10549-107H9	114.93	76.57
gastric cancer cell line:GSS	10560-108A2	287.38	65.90
gastrointestinal carcinoma cell line:ECC12	10615-108G3	51.40	48.66
giant cell carcinoma cell line:LU65	10487-107B1	0.57	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	145.98	70.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.47	32.92
glioblastoma cell line:A172, tech_rep1	10444-106F3	307.90	44.02
glioblastoma cell line:A172, tech_rep2	10444-106F3	307.98	49.01
glioblastoma cell line:T98G	10485-107A8	180.13	38.19
glioma cell line:GI-1	10413-106B8	174.55	10.25
globus pallidus - adult, donor10196	10175-103C4	162.55	109.34
globus pallidus, adult, donor10252	10161-103A8	130.83	48.82
globus pallidus, adult, donor10258	10367-105F7	147.87	43.81
globus pallidus, newborn, donor10223	10364-105F4	159.34	52.23
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	12.24
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	43.71
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	15.68
granulosa cell tumor cell line:KGN	10624-108H3	331.52	47.04
hIPS +CCl2, biol_rep1	14383-156B9	229.10	109.27
hIPS +CCl2, biol_rep2	14384-156C1	212.63	98.31
hIPS +CCl2, biol_rep3	14385-156C2	200.31	98.55
hIPS, biol_rep1	14380-156B6	146.60	76.18
hIPS, biol_rep2	14381-156B7	166.67	76.82
hIPS, biol_rep3	14382-156B8	204.14	150.07
hairy cell leukemia cell line:Mo	10712-109I1	0.29	66.95
heart - mitral valve, adult	10205-103F7	106.73	88.20
heart - pulmonic valve, adult	10206-103F8	94.13	86.29
heart - tricuspid valve, adult	10207-103F9	19.15	21.65
heart, adult, diseased post-infarction, donor1	10050-101G5	110.60	64.89
heart, adult, diseased, donor1	10051-101G6	67.71	143.51
heart, adult, pool1	10016-101C7	51.51	74.51
heart, fetal, pool1	10046-101G1	243.35	141.60
hepatic mesenchymal tumor cell line:LI90	10778-110G4	402.01	41.65
hepatoblastoma cell line:HuH-6	10633-108I3	168.86	48.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	426.07	10.50
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	392.28	8.86
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	439.68	11.01
hepatoma cell line:Li-7	10484-107A7	18.13	42.04
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.59	35.38
hippocampus - adult, donor10196	10169-103B7	320.80	195.89
hippocampus, adult, donor10252	10153-102I9	252.27	86.33
hippocampus, adult, donor10258	10374-105G5	207.15	140.42
hippocampus, newborn, donor10223	10363-105F3	211.84	90.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	176.39	75.07
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	107.80	60.67
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	166.56	72.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	358.05	161.83
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	339.03	148.73
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	405.04	173.10
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	378.66	165.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	325.94	133.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	358.27	170.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	377.45	118.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	394.72	150.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	449.09	127.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	84.66	47.57
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	94.82	55.52
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	86.40	73.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	352.80	165.52
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	334.90	155.68
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	400.81	149.93
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	275.99	91.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	277.38	134.14
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	346.44	133.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	372.16	115.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	372.18	110.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	449.58	139.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	141.88	69.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	140.65	71.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	187.41	102.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	343.98	130.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	290.45	103.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	355.58	146.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	366.64	125.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	335.40	133.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	407.12	122.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	433.32	114.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	451.30	150.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	462.75	112.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	140.32	76.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	174.25	90.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	178.54	107.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	442.53	154.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	507.51	159.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	505.68	210.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	400.62	149.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	412.19	136.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	350.89	151.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	367.56	115.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	556.06	145.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	395.20	133.08
immature langerhans cells, donor1	11904-125F5	0.24	19.86
immature langerhans cells, donor2	11905-125F6	0.00	11.88
insula, adult, pool1	10039-101F3	353.65	212.36
keratoacanthoma cell line:HKA-1	10791-110H8	29.59	1.30
kidney, adult, pool1	10017-101C8	119.25	73.39
kidney, fetal, pool1	10045-101F9	280.04	108.44
large cell lung carcinoma cell line:IA-LM	10509-107D5	191.73	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	112.25	60.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	145.88	0.00
left atrium, adult, donor1	10079-102A7	99.71	118.23
left ventricle, adult, donor1	10078-102A6	42.98	90.01
leiomyoblastoma cell line:G-402	10721-110A1	266.77	93.85
leiomyoma cell line:10964C	10569-108B2	428.58	47.42
leiomyoma cell line:15242A	10570-108B3	420.11	41.85
leiomyoma cell line:15425	10571-108B4	435.37	48.08
leiomyosarcoma cell line:Hs 5.T	10722-110A2	273.02	19.05
lens epithelial cell line:SRA 01/04	10647-109A8	118.15	107.69
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	22.43	6.49
liposarcoma cell line:KMLS-1	10782-110G8	568.60	71.70
liposarcoma cell line:SW 872	10726-110A6	310.93	34.48
liver, adult, pool1	10018-101C9	263.35	47.00
liver, fetal, pool1	10086-102B5	158.04	42.33
locus coeruleus - adult, donor10196	10182-103D2	151.22	122.64
locus coeruleus, adult, donor10252	10165-103B3	155.02	70.31
locus coeruleus, adult, donor10258	10375-105G6	193.26	91.98
locus coeruleus, newborn, donor10223	10362-105F2	211.57	136.70
lung adenocarcinoma cell line:A549	10499-107C4	49.68	42.76
lung adenocarcinoma cell line:PC-14	10408-106B3	463.97	26.20
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	184.28	0.00
lung, adult, pool1	10019-101D1	93.44	19.85
lung, fetal, donor1	10068-101I5	327.08	92.47
lung, right lower lobe, adult, donor1	10075-102A3	61.86	38.03
lymph node, adult, donor1	10077-102A5	43.08	48.28
lymphangiectasia cell line:DS-1	10727-110A7	0.66	12.93
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.00	71.99
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	39.93
mature adipocyte, donor1	12231-129F8	65.71	15.98
mature adipocyte, donor2	12232-129F9	62.05	17.64
mature adipocyte, donor3	12233-129G1	68.99	29.40
mature adipocyte, donor4	12234-129G2	56.59	22.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	124.85	51.23
medial frontal gyrus - adult, donor10196	10170-103B8	245.91	195.15
medial frontal gyrus, adult, donor10252	10150-102I6	173.24	136.27
medial frontal gyrus, adult, donor10258	10368-105F8	206.18	195.38
medial frontal gyrus, newborn, donor10223	10352-105E1	220.07	104.06
medial temporal gyrus - adult, donor10196	10183-103D3	341.38	220.22
medial temporal gyrus, adult, donor10252	10156-103A3	177.63	123.94
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	229.22	105.94
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	143.54	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	226.13	130.65
medulla oblongata - adult, donor10196	10174-103C3	192.10	116.17
medulla oblongata, adult, donor10252	10155-103A2	160.07	62.54
medulla oblongata, adult, pool1	10038-101F2	286.59	103.75
medulla oblongata, newborn, donor10223	10361-105F1	182.96	71.87
medulloblastoma cell line:D283 Med	10838-111E1	155.65	140.15
medulloblastoma cell line:ONS-76	10759-110E3	100.14	50.87
melanoma cell line:COLO 679	10514-107E1	24.58	39.10
melanoma cell line:G-361	10465-106H6	139.26	55.92
meningioma cell line:HKBMM	10691-109F7	122.47	27.50
merkel cell carcinoma cell line:MKL-1	10843-111E6	335.72	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	174.72	84.77
mesenchymal precursor cell - adipose, donor1	11747-123G1	427.16	36.67
mesenchymal precursor cell - adipose, donor2	11748-123G2	207.05	22.72
mesenchymal precursor cell - adipose, donor3	11749-123G3	347.43	29.82
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	272.52	30.48
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	301.56	32.74
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	383.13	46.50
mesenchymal precursor cell - cardiac, donor1	11752-123G6	117.05	18.71
mesenchymal precursor cell - cardiac, donor2	11753-123G7	285.47	27.72
mesenchymal precursor cell - cardiac, donor3	11754-123G8	385.84	42.44
mesenchymal precursor cell - cardiac, donor4	11755-123G9	308.57	29.98
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	303.59	28.74
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	111.65	32.94
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	392.56	39.71
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	474.75	45.73
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	301.55	17.56
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	271.75	34.15
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	272.69	30.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	401.95	38.30
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	251.31	28.53
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	325.62	34.82
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	271.26	28.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	211.69	39.39
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	325.65	33.77
mesenchymal stem cell line:Hu5/E18	10568-108B1	269.87	38.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	444.80	32.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	394.93	39.90
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	479.54	43.98
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	450.42	34.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	386.69	33.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	452.85	35.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	413.80	33.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	424.00	41.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	193.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	491.46	51.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	461.59	39.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	479.26	47.83
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	671.73	56.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	447.43	43.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	468.74	44.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	516.76	43.39
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	360.94	41.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	325.39	56.81
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	360.51	40.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	360.84	36.37
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	344.37	38.91
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	300.12	28.62
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	320.31	27.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	302.22	41.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	293.07	30.80
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	328.94	33.37
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	321.39	31.43
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	291.21	34.12
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	135.26
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	331.89	44.97
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	205.56	26.56
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	186.98	23.64
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	191.61	35.93
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	196.30	34.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	170.73	27.30
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	158.09	31.78
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	96.09	25.35
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	106.91	20.26
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	135.00	22.72
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	76.87	27.20
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	102.72	64.20
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	106.70	28.91
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	163.78	50.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	143.55	39.25
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	152.66	48.34
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	203.10	53.60
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	200.61	50.15
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	196.39	78.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	109.85	23.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	131.05	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	99.67	25.53
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	158.94	33.93
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	125.58	30.18
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	168.07	44.82
mesodermal tumor cell line:HIRS-BM	10696-109G3	520.71	34.04
mesothelioma cell line:ACC-MESO-1	10493-107B7	292.47	63.31
mesothelioma cell line:ACC-MESO-4	10494-107B8	537.25	91.51
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	205.13	29.92
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	168.41	32.37
mesothelioma cell line:Mero-25	10850-111F4	130.50	45.62
mesothelioma cell line:Mero-41	10851-111F5	406.56	52.81
mesothelioma cell line:Mero-48a	10852-111F6	231.17	48.71
mesothelioma cell line:Mero-82	10853-111F7	50.20	27.33
mesothelioma cell line:Mero-83	10854-111F8	333.80	56.68
mesothelioma cell line:Mero-84	10855-111F9	205.76	58.14
mesothelioma cell line:Mero-95	10856-111G1	331.68	53.00
mesothelioma cell line:NCI-H2052	10847-111F1	222.96	26.34
mesothelioma cell line:NCI-H226	10846-111E9	154.21	36.92
mesothelioma cell line:NCI-H2452	10848-111F2	258.97	21.35
mesothelioma cell line:NCI-H28	10845-111E8	76.34	100.01
mesothelioma cell line:No36	10857-111G2	271.73	64.26
mesothelioma cell line:ONE58	10858-111G3	422.41	42.00
migratory langerhans cells, donor1	11901-125F2	1.15	21.69
migratory langerhans cells, donor2	11902-125F3	0.85	20.27
migratory langerhans cells, donor3	11903-125F4	4.67	33.56
mixed mullerian tumor cell line:HTMMT	10689-109F5	126.35	9.47
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	189.26	17.38
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	30.41	52.98
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.71	22.84
myelodysplastic syndrome cell line:SKM-1	10772-110F7	13.31	0.00
myeloma cell line:PCM6	10474-106I6	132.83	28.66
myxofibrosarcoma cell line:MFH-ino	10600-108E6	493.59	45.15
myxofibrosarcoma cell line:NMFH-1	10684-109E9	192.81	42.17
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.92	12.15
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.00	15.66
nasal epithelial cells, donor2	12227-129F4	176.08	21.53
neuroblastoma cell line:CHP-134	10508-107D4	91.56	64.65
neuroblastoma cell line:NB-1	10539-107G8	216.46	152.66
neuroblastoma cell line:NBsusSR	10607-108F4	363.78	86.46
neuroblastoma cell line:NH-12	10555-107I6	156.91	82.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	809.41	67.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	546.57	54.64
neuroectodermal tumor cell line:TASK1	10774-110F9	468.13	86.14
neuroepithelioma cell line:SK-N-MC	10728-110A8	796.61	48.95
neurofibroma cell line:Hs 53.T	10729-110A9	409.63	56.43
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	258.75	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	159.30	44.83
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	561.70	49.69
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	460.89	28.64
nucleus accumbens, adult, pool1	10037-101F1	279.44	177.17
occipital cortex - adult, donor10196	10172-103C1	177.19	358.51
occipital cortex, adult, donor10252	10163-103B1	143.84	114.05
occipital cortex, newborn, donor10223	10355-105E4	192.16	137.57
occipital lobe, adult, donor1	10076-102A4	146.16	134.35
occipital lobe, fetal, donor1	10073-102A1	332.98	139.89
occipital pole, adult, pool1	10036-101E9	245.91	215.00
olfactory region, adult	10195-103E6	211.49	108.33
optic nerve, donor1	10277-104E7	70.04	58.03
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.08	38.05
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.36	36.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.44	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.35	16.52
osteoclastoma cell line:Hs 706.T	10704-109H2	219.89	32.63
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	115.86	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	537.15	0.64
ovary, adult, pool1	10020-101D2	183.61	38.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	713.67	81.76
pancreas, adult, donor1	10049-101G4	187.19	26.34
pancreatic carcinoma cell line:NOR-P1	10698-109G5	191.20	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	128.96	54.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	110.94	74.51
paracentral gyrus, adult, pool1	10035-101E8	236.31	186.61
parietal cortex, adult, donor10258	10373-105G4	298.74	140.93
parietal lobe - adult, donor10196	10171-103B9	170.23	161.76
parietal lobe, adult, donor10252	10157-103A4	151.64	144.80
parietal lobe, adult, pool1	10034-101E7	238.80	184.17
parietal lobe, fetal, donor1	10072-101I9	353.02	180.39
parietal lobe, newborn, donor10223	10356-105E5	235.16	126.74
parotid gland, adult	10199-103F1	280.58	20.97
penis, adult	10200-103F2	78.96	35.45
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	251.20	42.21
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.75	0.15
pineal gland - adult, donor10196	10179-103C8	143.20	125.78
pineal gland, adult, donor10252	10160-103A7	97.72	81.73
pineal gland, adult, donor10258	10377-105G8	133.57	108.48
pituitary gland - adult, donor10196	10180-103C9	735.58	195.28
pituitary gland, adult, donor10252	10162-103A9	621.25	239.74
pituitary gland, adult, donor10258	10378-105G9	623.96	251.12
placenta, adult, pool1	10021-101D3	351.10	18.60
plasma cell leukemia cell line:ARH-77	10840-111E3	96.94	39.99
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	535.55	49.96
pons, adult, pool1	10033-101E6	226.44	127.72
postcentral gyrus, adult, pool1	10032-101E5	252.02	191.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74
prostate cancer cell line:DU145	10490-107B4	66.13	53.89
prostate cancer cell line:PC-3	10439-106E7	455.02	121.42
prostate, adult, pool1	10022-101D4	135.95	31.11
putamen, adult, donor10196	10176-103C5	384.55	176.81
putamen, adult, donor10252	10152-102I8	103.92	23.53
putamen, adult, donor10258, tech_rep1	10372-105G3	187.96	95.07
putamen, adult, donor10258, tech_rep2	10372-105G3	187.49	117.18
putamen, newborn, donor10223	10365-105F5	163.43	143.93
rectal cancer cell line:TT1TKB	10469-106I1	75.06	29.38
rectum, fetal, donor1	10067-101I4	240.64	102.93
renal cell carcinoma cell line:OS-RC-2	10411-106B6	327.96	40.92
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	41.42	21.95
retina, adult, pool1	10030-101E3	267.58	99.30
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	393.56	100.20
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	261.52	67.21
sacrococcigeal teratoma cell line:HTST	10695-109G2	668.43	54.57
salivary acinar cells, donor1	11771-123I7	78.82	58.27
salivary acinar cells, donor2	11772-123I8	59.48	53.70
salivary acinar cells, donor3	11773-123I9	68.19	50.98
salivary gland, adult, pool1	10093-102C3	347.18	46.33
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	76.39	6.15
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	73.12	6.35
seminal vesicle, adult	10201-103F3	200.52	66.13
serous adenocarcinoma cell line:JHOS-2	10639-108I9	111.26	17.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	45.29	31.20
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	114.40	37.13
serous cystadenocarcinoma cell line:HTOA	10693-109F9	292.28	34.52
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	154.74
signet ring carcinoma cell line:NUGC-4	10483-107A6	42.06	59.35
skeletal muscle - soleus muscle, donor1	10282-104F3	77.32	50.36
skeletal muscle, adult, pool1	10023-101D5	73.16	23.03
skeletal muscle, fetal, donor1	10066-101I3	312.56	36.18
skin, adult, donor1	10074-102A2	74.64	27.14
skin, fetal, donor1	10065-101I2	260.70	47.97
small cell cervical cancer cell line:HCSC-1	10800-110I8	188.44	72.71
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	281.48	122.30
small cell lung carcinoma cell line:DMS 144	10841-111E4	414.99	133.00
small cell lung carcinoma cell line:LK-2	10541-107H1	40.55	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	354.83	37.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	151.02	119.64
small intestine, adult, pool1	10024-101D6	41.69	57.57
small intestine, fetal, donor1	10064-101I1	159.95	75.92
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	446.22	103.09
smooth muscle, adult, pool1	10048-101G3	76.50	35.41
somatostatinoma cell line:QGP-1	10781-110G7	202.89	128.38
spinal cord - adult, donor10196	10181-103D1	190.41	82.59
spinal cord, adult, donor10252	10159-103A6	150.22	38.64
spinal cord, adult, donor10258	10369-105F9	269.80	103.77
spinal cord, fetal, donor1	10056-101H2	434.20	96.35
spinal cord, newborn, donor10223	10359-105E8	211.24	72.56
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	366.67	44.21
spleen, adult, pool1	10025-101D7	62.78	33.59
spleen, fetal, pool1	10044-101F8	123.23	40.12
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	68.32	14.70
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.82	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	203.03	21.32
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.25	30.49
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.75	12.94
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	85.57	12.28
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	276.27	79.54
stomach, fetal, donor1	10062-101H8	322.53	101.46
submaxillary gland, adult	10202-103F4	156.66	37.60
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	84.74	32.82
substantia nigra, adult, donor10258	10371-105G2	202.76	162.42
substantia nigra, newborn, donor10223	10358-105E7	127.89	72.07
synovial sarcoma cell line:HS-SY-II	10441-106E9	372.79	13.76
temporal lobe, adult, pool1	10031-101E4	312.63	189.89
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	464.40	159.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	509.86	155.16
tenocyte, donor1	11763-123H8	639.90	37.35
tenocyte, donor2	11765-123I1	211.35	32.81
tenocyte, donor3	11768-123I4	410.70	32.25
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	258.00	245.42
teratocarcinoma cell line:NCR-G1	10798-110I6	182.36	66.59
teratocarcinoma cell line:PA-1	10807-111A6	50.83	69.28
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	125.93	72.74
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.02	66.56
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	37.30	31.52
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	24.10	50.81
testis, adult, pool1	10026-101D8	241.27	59.81
testis, adult, pool2	10096-102C6	356.36	103.30
thalamus - adult, donor10196	10168-103B6	193.20	174.43
thalamus, adult, donor10252	10154-103A1	125.50	55.48
thalamus, adult, donor10258, tech_rep1	10370-105G1	283.29	146.26
thalamus, adult, donor10258, tech_rep2	10370-105G1	136.03	102.44
thalamus, newborn, donor10223	10366-105F6	270.40	155.34
throat, adult	10209-103G2	71.90	38.70
throat, fetal, donor1	10061-101H7	311.71	74.35
thymic carcinoma cell line:Ty-82	10803-111A2	287.17	23.25
thymus, adult, pool1	10027-101D9	160.56	60.44
thymus, fetal, pool1	10043-101F7	152.74	75.23
thyroid carcinoma cell line:KHM-5M	10776-110G2	90.95	9.71
thyroid carcinoma cell line:TCO-1	10783-110G9	165.95	91.50
thyroid, adult, pool1	10028-101E1	165.82	34.90
thyroid, fetal, donor1	10060-101H6	276.06	79.89
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	30.80
tongue, adult	10203-103F5	53.73	40.70
tongue, fetal, donor1	10059-101H5	166.70	58.72
tonsil, adult, pool1	10047-101G2	118.11	66.92
trachea, adult, pool1	10029-101E2	139.47	36.07
trachea, fetal, donor1	10058-101H4	285.06	56.55
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	382.26	55.98
transitional-cell carcinoma cell line:5637	10418-106C4	126.65	74.06
transitional-cell carcinoma cell line:JMSU1	10492-107B6	102.32	0.00
tridermal teratoma cell line:HGRT	10694-109G1	956.97	38.05
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	35.38	49.61
umbilical cord, fetal, donor1	10057-101H3	210.74	47.99
uterus, adult, pool1	10100-102D1	183.77	60.57
uterus, fetal, donor1	10055-101H1	376.27	62.97
vagina, adult	10204-103F6	3.88	16.15
vein, adult	10191-103E2	55.90	37.04
xeroderma pigentosum b cell line:XPL 17	10563-108A5	84.92	16.02